
Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-05-14 14:00:06Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock outperformed its sector peers with a 5.8% gain on 14 May 2026, supported by robust volume and a notable increase in futures and options participation.
Read full news article
Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-05-14 13:00:06Zydus Lifesciences Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance against its sector and broader indices, coupled with rising volumes and positive price action, suggests a shift in investor sentiment towards a more bullish stance.
Read full news article
Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-05-14 12:00:05Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector and broader indices, supported by robust volume and positive price action, prompting a recent upgrade in its mojo grade to Hold from Sell.
Read full news article
Zydus Lifesciences Ltd Rallies 5.15% and Approaches Key Moving Averages — Momentum Builds
2026-05-14 11:16:01The Sensex remained flat on 14 Jun 2026, but Zydus Lifesciences Ltd surged 5.15%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 3.9 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly subdued market environment.
Read full news article
Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum
2026-05-14 11:00:06Zydus Lifesciences Ltd has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector peers with a 4.81% gain on 14 May 2026, supported by rising volumes and positive price action, prompting a recent upgrade in its Mojo Grade from Sell to Hold.
Read full news article
Zydus Lifesciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation
2026-05-13 08:18:48Zydus Lifesciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across key parameters including quality, valuation, financial trends, and technical indicators. This shift comes amid a backdrop of mixed quarterly results but strong long-term fundamentals and improved market positioning.
Read full news article
Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-13 08:01:17Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. Despite a day-on-day price decline of 2.71%, the stock’s weekly and monthly technical indicators present a complex picture, reflecting both bullish and bearish signals that investors should carefully analyse.
Read full news article
Zydus Lifesciences Sees Sharp Open Interest Surge Amid Volatile Trading
2026-05-12 12:00:08Zydus Lifesciences Ltd has witnessed a notable 12.19% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite underperforming its sector and the broader Sensex, the surge in open interest combined with elevated volatility and rising delivery volumes suggests evolving directional bets among traders.
Read full news article
Zydus Lifesciences Sees Sharp Open Interest Surge Amid Mixed Market Signals
2026-05-12 11:00:07Zydus Lifesciences Ltd has witnessed a notable 12.3% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders.
Read full news articleBoard Meeting Intimation for Approval Of Audited Financial Results For The Quarter / Year Ended On March 31 2026
08-May-2026 | Source : BSEZydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 inter alia to consider and approve audited financial results for the quarter / year ended on March 31 2026 and to recommend final dividend for the Financial Year ended March 31 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
06-May-2026 | Source : BSEUSFDA inspection concludes at Zydus Biologics Injectable plant Ahmedabad.
Receipt Of Demand Order-In-Original From Deputy Commissioner Of CGST & Central Excise Ahmedabad North Commissionerate
05-May-2026 | Source : BSEReceipt of Demand Order-In-Original from Deputy Commissioner of CGST & Central Excise Ahmedabad North Commissionerate by Zydus VTEC Limited a wholly owned subsidiary company.
Corporate Actions
19 May 2026
Zydus Lifesciences Ltd has declared 1100% dividend, ex-date: 25 Jul 25
Zydus Lifesciences Ltd has announced 1:5 stock split, ex-date: 06 Oct 15
Zydus Lifesciences Ltd has announced 1:2 bonus issue, ex-date: 05 Apr 10
No Rights history available






